Recursion Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	525.11	594.35	391.57	549.91	285.12	262.13
Short-Term Investments	-	-	-	-	231.45	-
Cash & Short-Term Investments	525.11	594.35	391.57	549.91	516.56	262.13
Cash Growth	10.70%	51.79%	-28.79%	6.46%	97.07%	-
Accounts Receivable	-	-	-	-	0.03	0.16
Other Receivables	21.61	49.17	3.09	2.75	9.06	-
Total Trade Receivables	21.61	49.17	3.09	2.75	9.09	0.16
Other Current Assets	40.44	70.75	43.48	17.15	9.07	4.16
Total Current Assets	587.16	714.27	438.14	569.81	534.72	266.44
Net Property, Plant & Equipment	193.6	233.21	120.17	121.45	64.73	25.97
Other Intangible Assets	341.32	335.86	36.44	1.31	1.39	1.69
Goodwill	164.27	148.87	52.06	0.8	0.8	0.8
Other Long-Term Assets	16	16.39	6.89	7.92	8.72	3.69
Total Assets	1,302	1,449	653.7	701.29	610.35	298.59
Accounts Payable	19.31	21.61	3.95	4.59	2.82	1.07
Accrued Expenses	84.54	81.87	46.64	32.9	32.33	10.49
Short-Term Debt	8.75	8.43	0.04	0.1	0.09	1.07
Current Portion of Leases	11.73	13.8	6.12	5.95	1.42	0.47
Unearned Revenue	39.69	61.77	36.43	56.73	10	10
Total Current Liabilities	164.03	187.47	93.17	100.27	46.66	23.1
Long-Term Debt	14.2	19.02	1.1	0.54	0.63	11.41
Long-Term Leases	53.4	67.25	43.41	44.42	13.45	5.38
Other Long-Term Liabilities	151.59	140.07	52.58	70.26	6.67	16.67
Total Long-Term Liabilities	219.18	226.34	97.09	115.22	20.75	33.46
Total Liabilities	383.21	413.82	190.26	215.48	67.41	56.56
Preferred Stock	-	-	-	-	-	448.31
Common Stock	0	0	0	0	0	-
Additional Paid-in Capital	2,681	2,474	1,431	1,125	943.14	7.31
Accumulated Other Comprehensive Income	43.62	-7.64	-	-	-0.13	-
Retained Earnings	-1,806	-1,431	-967.62	-639.56	-400.08	-213.6
Total Common Shareholders' Equity	919.15	1,035	463.44	485.81	542.94	242.02
Shareholders' Equity	919.15	1,035	463.44	485.81	542.94	-206.29
Total Liabilities & Equity	1,302	1,449	653.7	701.29	610.35	298.59
Total Debt	88.08	108.49	50.67	51.01	15.59	18.34
Net Cash (Debt)	437.04	485.86	340.89	498.91	500.97	243.79
Net Cash Growth	-10.05%	42.52%	-31.67%	-0.41%	105.49%	-
Net Cash Per Share	1.36	1.77	1.64	2.84	4.00	11.19
Book Value	919.15	1,035	463.44	485.81	542.94	242.02
Book Value Per Share	2.86	3.77	2.23	2.77	4.33	11.11
Tangible Book Value	413.56	550.05	374.94	483.7	540.75	239.53
Tangible Book Value Per Share	1.29	2.01	1.80	2.76	4.31	11.00

Updated Aug 5, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q